210 related articles for article (PubMed ID: 2017228)
21. Proteinuria in children with sickle cell disease.
Marsenic O; Couloures KG; Wiley JM
Nephrol Dial Transplant; 2008 Feb; 23(2):715-20. PubMed ID: 18065783
[TBL] [Abstract][Full Text] [Related]
22. Different seizure types and skin lesions in oculocerebrorenal syndrome of Lowe.
Erdogan F; Ismailogullari S; Soyuer I; Ferahbas A; Poyrazoglu H
J Child Neurol; 2007 Apr; 22(4):427-31. PubMed ID: 17621522
[TBL] [Abstract][Full Text] [Related]
23. [Sodium excretion in children with lithogenic disorders].
Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
[TBL] [Abstract][Full Text] [Related]
24. [Acute tubulointerstitial nephritis in children].
Nikolić V; Bogdanović R; Ognjanović M; Stajić N
Srp Arh Celok Lek; 2001; 129 Suppl 1():23-7. PubMed ID: 15637986
[TBL] [Abstract][Full Text] [Related]
25. Renal outcome 25 years after donor nephrectomy.
Goldfarb DA; Matin SF; Braun WE; Schreiber MJ; Mastroianni B; Papajcik D; Rolin HA; Flechner S; Goormastic M; Novick AC
J Urol; 2001 Dec; 166(6):2043-7. PubMed ID: 11696703
[TBL] [Abstract][Full Text] [Related]
26. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.
Tuttle KR; Bruton JL; Perusek MC; Lancaster JL; Kopp DT; DeFronzo RA
N Engl J Med; 1991 Jun; 324(23):1626-32. PubMed ID: 2030719
[TBL] [Abstract][Full Text] [Related]
27. [Renal tubular function in children with hypercalciuria].
Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
[TBL] [Abstract][Full Text] [Related]
28. Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome.
Bernardini I; Rizzo WB; Dalakas M; Bernar J; Gahl WA
J Clin Invest; 1985 Apr; 75(4):1124-30. PubMed ID: 3988933
[TBL] [Abstract][Full Text] [Related]
29. Cataracts and glaucoma in patients with oculocerebrorenal syndrome.
Kruger SJ; Wilson ME; Hutchinson AK; Peterseim MM; Bartholomew LR; Saunders RA
Arch Ophthalmol; 2003 Sep; 121(9):1234-7. PubMed ID: 12963605
[TBL] [Abstract][Full Text] [Related]
30. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
Lin JL; Lin-Tan DT; Hsu KH; Yu CC
N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
[TBL] [Abstract][Full Text] [Related]
31. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
32. Ultrastructural, neurological, and glycosaminoglycan abnormalities in lowe's syndrome.
Wisniewski KE; Kieras FJ; French JH; Houck GE; Ramos PL
Ann Neurol; 1984 Jul; 16(1):40-9. PubMed ID: 6087720
[TBL] [Abstract][Full Text] [Related]
33. Complete oculocerebrorenal phenotype of Lowe syndrome in a female patient with half reduction of inositol polyphosphate 5-phosphatase.
Yamamoto K; Hasegawa Y; Ohata Y; Satomura K; Mizoguchi Y; Shimotsuji T; Yamamoto T
CEN Case Rep; 2020 May; 9(2):95-100. PubMed ID: 31707643
[TBL] [Abstract][Full Text] [Related]
34. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.
Klahr S; Levey AS; Beck GJ; Caggiula AW; Hunsicker L; Kusek JW; Striker G
N Engl J Med; 1994 Mar; 330(13):877-84. PubMed ID: 8114857
[TBL] [Abstract][Full Text] [Related]
35. Factors predictive of renal involvement in patients with primary Sjögren's syndrome.
Pertovaara M; Korpela M; Pasternack A
Clin Nephrol; 2001 Jul; 56(1):10-8. PubMed ID: 11499654
[TBL] [Abstract][Full Text] [Related]
36. The oculocerebrorenal syndrome of Lowe: an update.
Bökenkamp A; Ludwig M
Pediatr Nephrol; 2016 Dec; 31(12):2201-2212. PubMed ID: 27011217
[TBL] [Abstract][Full Text] [Related]
37. A balanced de novo X/autosome translocation in a girl with manifestations of Lowe syndrome.
Hodgson SV; Heckmatt JZ; Hughes E; Crolla JA; Dubowitz V; Bobrow M
Am J Med Genet; 1986 Mar; 23(3):837-47. PubMed ID: 3953680
[TBL] [Abstract][Full Text] [Related]
38. Evidence for a discrete behavioral phenotype in the oculocerebrorenal syndrome of Lowe.
Kenworthy L; Charnas L
Am J Med Genet; 1995 Nov; 59(3):283-90. PubMed ID: 8599350
[TBL] [Abstract][Full Text] [Related]
39. Selective proximal renal tubular involvement and dyslipidemia in two cousins with oculocerebrorenal syndrome of Lowe.
Topaloğlu R; Ludwig M; Çelebi Tayfur A
Turk J Pediatr; 2013; 55(3):331-4. PubMed ID: 24217083
[TBL] [Abstract][Full Text] [Related]
40. [Lowe syndrome: report of one case].
Wang CL; Liu CY; Yuh YS; Chu ML
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993; 34(1):45-53. PubMed ID: 8333287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
